Cleared Traditional

K851104 - AMERLEX-M LUTEINIZING HORMONE RADIOIMMUNO-KIT

K851104 is an FDA 510(k) clearance for AMERLEX-M LUTEINIZING HORMONE RADIOIMMU..., manufactured by Amersham Corp.. The device is a Class 1 Chemistry device with product code CEP cleared through the Traditional 510(k) pathway after a 22-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1985
Decision
22d
Days
Class 1
Risk

K851104 is an FDA 510(k) clearance for the AMERLEX-M LUTEINIZING HORMONE RADIOIMMUNO-KIT. Classified as Radioimmunoassay, Luteinizing Hormone (product code CEP), Class I - General Controls.

Submitted by Amersham Corp. (Arlington Heights, US). The FDA issued a Cleared decision on April 10, 1985 after a review of 22 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1485 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K851104

510(k) Number K851104 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 19, 1985
Decision Date April 10, 1985
Days to Decision 22 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
67d faster than avg
Panel avg: 89d · This submission: 22d
Pathway characteristics
Predicate-based equivalence.

CEP Device Classification - Class 1, General Controls

Product Code CEP Radioimmunoassay, Luteinizing Hormone
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1485
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CEP Radioimmunoassay, Luteinizing Hormone

All 142
Devices cleared under the same product code (CEP) and FDA review panel - the closest regulatory comparables to K851104.
QUIDEL QUEST OVULATION TEST
K852146 · Quidel Corp. · Jul 1985
BLHI LUTEINIZING HORMONE
K851332 · Euro-Diagnostics BV · Jul 1985
SIMULTANEOUS LH/FSH SYSTEM BY RIA
K852376 · American Bioclinical, Inc. · Jul 1985
OVU STICK SELF-TEST -MODIFICATION
K850480 · Monoclonal Antibodies, Inc. · Mar 1985
OVUSTICK SELF-TEST
K843284 · Monoclonal Antibodies, Inc. · Dec 1984
ENZYME IMMUNOASSAY FOR DETECTION HORM
K841545 · Btc Diagnostics, Inc. · Nov 1984